Trials / Completed
CompletedNCT04962035
Neurocognitive Follow-Up (FU) Study
Neurocognitive Scores of Predominantly Formula Fed Preterm Infants in Early Childhood Years
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 17 Months – 25 Months
- Healthy volunteers
- Accepted
Summary
This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).
Detailed description
This is a follow-up study of a recently completed multi-center, prospective, single-arm, open-label interventional trial (17.14.INF - Alprem RTF: NCT03728764) evaluating the growth of pre-term infants receiving a two-stage PTF feeding system while in the neonatal care unit and continuing until 30 days post-discharge. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA). The timing of the cognitive assessments aligns with routine check-up visits and reflect the period at which developmental delays may first become evident.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neurocognitive Follow-up | Standard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions. |
Timeline
- Start date
- 2021-03-26
- Primary completion
- 2021-11-30
- Completion
- 2021-12-22
- First posted
- 2021-07-14
- Last updated
- 2023-03-24
Locations
3 sites across 2 countries: Poland, Slovakia
Source: ClinicalTrials.gov record NCT04962035. Inclusion in this directory is not an endorsement.